Northwestern Inventor: Marcus Peter Feinberg School of Medicine Medicine and Biochemistry & Molecular Genetics
NUAgo is developing single construct short RNAs that kill tumor cells selectively as a therapy for treatment resistant cancers.
NUAgo Therapeutics, Inc. Website
Life Sciences > Therapeutics